[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN100548995C - The preparation method of 2-thiazole carboxaldehyde compounds - Google Patents

The preparation method of 2-thiazole carboxaldehyde compounds Download PDF

Info

Publication number
CN100548995C
CN100548995C CNB2007100688666A CN200710068866A CN100548995C CN 100548995 C CN100548995 C CN 100548995C CN B2007100688666 A CNB2007100688666 A CN B2007100688666A CN 200710068866 A CN200710068866 A CN 200710068866A CN 100548995 C CN100548995 C CN 100548995C
Authority
CN
China
Prior art keywords
formula
reaction
thiazole
compounds
grignard reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2007100688666A
Other languages
Chinese (zh)
Other versions
CN101050204A (en
Inventor
李昌龙
楼科侠
徐明东
张达
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Original Assignee
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Jiuzhou Pharmaceutical Co Ltd filed Critical Zhejiang Jiuzhou Pharmaceutical Co Ltd
Priority to CNB2007100688666A priority Critical patent/CN100548995C/en
Publication of CN101050204A publication Critical patent/CN101050204A/en
Application granted granted Critical
Publication of CN100548995C publication Critical patent/CN100548995C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Thiazole And Isothizaole Compounds (AREA)

Abstract

The invention discloses the preparation method of a kind of 2-thiazole carboxaldehyde compounds (formula I).With 2-bromo thiazole compounds is raw material, prepares its Grignard reagent by halogen-Ge Shi permutoid reaction, obtains 2-thiazoles fragrance Grignard reagent; Under certain condition with this Grignard reagent and Carbox amide reaction, make highly purified 2-thiazole carboxaldehyde compounds through hydrolysis with high yield more then.This method reaction conditions gentleness, speed is fast, yield is high, and is simple to operate, be easy to industrialization.

Description

2-噻唑甲醛类化合物的制备方法 The preparation method of 2-thiazole formaldehyde compound

技术领域 technical field

本发明属于化工技术领域,涉及药物类产品及其中间体的制备,具体为2-噻唑甲醛类化合物的制备方法。The invention belongs to the technical field of chemical industry and relates to the preparation of pharmaceutical products and intermediates thereof, in particular to the preparation method of 2-thiazole formaldehyde compounds.

背景技术 Background technique

2-噻唑甲醛类化合物可用作合成含有噻唑杂环官能团的化合物,包括农药类、染料类、医药类产品及其中间体。2-thiazole formaldehyde compounds can be used to synthesize compounds containing thiazole heterocyclic functional groups, including pesticides, dyes, pharmaceutical products and their intermediates.

例如,用作抗病毒药物的合成(WO-A2-02/096359Merck,WO-A1-2004/037818&WO2006045613Glaxo),用作治疗肥胖症杂环化合物的制备(WO2006019957 Schering Corp.)用作抗过敏药物的合成(WO9011278&JP-A2-04264076 Green Cross Corp,WO9714686 AstraPharma),用作抗生素合成(J of Antibiotics 1988 41-1 134-8Pfizer Inc.)等。For example, for the synthesis of antiviral drugs (WO-A2-02/096359Merck, WO-A1-2004/037818&WO2006045613Glaxo), for the preparation of heterocyclic compounds for treating obesity (WO2006019957 Schering Corp.) for the synthesis of antiallergic drugs (WO9011278&JP-A2-04264076 Green Cross Corp, WO9714686 AstraPharma), used for antibiotic synthesis (J of Antibiotics 1988 41-1 134-8Pfizer Inc.), etc.

已知2-噻唑甲醛类化合物可由如下方法制备:Known 2-thiazole formaldehyde compounds can be prepared by the following method:

(1)由2-二氯甲基噻唑类化合物水解;(1) hydrolyzed by 2-dichloromethylthiazole compounds;

(2)由2-甲基噻唑类化合物直接氧化;(2) direct oxidation by 2-methylthiazole compounds;

(3)由2-氨基噻唑化合物重氮化,再与肟类似物反应;(3) diazotization by 2-aminothiazole compound, and then react with oxime analog;

(4)以2-卤代噻唑类化合物为原料,制备2-噻唑类化合物锂盐,再与DMF反应。(4) Using 2-halogenated thiazole compounds as raw materials to prepare lithium salts of 2-thiazole compounds, and then reacting with DMF.

但是以上这些方法都不够理想,比如第一个方法中的原料需由2-甲基噻唑制备,2-甲基噻唑不易获得;第二个方法中需要用到高温、高压、强酸等苛刻的反应条件,并且三废污染严重;第三个方法虽然原料价廉易得,但收率很低,约10%;第四个方法由于Li-C键的强极性,活泼性高,需要在超低温(-75℃)条件下反应,因此不易工业化。However, these methods are not ideal enough. For example, the raw material in the first method needs to be prepared by 2-methylthiazole, which is not easy to obtain; in the second method, harsh reactions such as high temperature, high pressure, and strong acid are required. conditions, and the pollution of the three wastes is serious; although the third method is cheap and easy to get raw materials, the yield is very low, about 10%; the fourth method needs to be processed at ultra-low temperature ( -75°C) conditions, so it is not easy to industrialize.

发明内容 Contents of the invention

为解决现有技术存在的上述问题,本发明的目的是提供一种反应条件温和,反应速度快、收率高,操作简单、易于工业化的制备2-噻唑甲醛类化合物的方法。In order to solve the above-mentioned problems in the prior art, the object of the present invention is to provide a method for preparing 2-thiazole carboxaldehyde compounds with mild reaction conditions, fast reaction speed, high yield, simple operation and easy industrialization.

本发明提供2-噻唑甲醛类化合物(式I)的制备方法为如下步骤:The present invention provides the preparation method of 2-thiazole formaldehyde compounds (formula I) as follows:

Figure C20071006886600041
式I
Figure C20071006886600041
Formula I

(1)用2-溴噻唑官能团衍生物(式II)与卤代烃格氏试剂RMgBr(式III)进行格氏交换反应,得到杂芳基格氏试剂(式IV);(1) Carry out Grignard exchange reaction with 2-bromothiazole functional group derivative (formula II) and halogenated hydrocarbon Grignard reagent RMgBr (formula III) to obtain heteroaryl Grignard reagent (formula IV);

Figure C20071006886600051
式II    RMgBr 式III
Figure C20071006886600051
Formula II RMgBr Formula III

(2)将杂芳基格氏试剂(式IV)与酰胺类化合物(式V)反应,得到中间体络合物(式VI);(2) reacting a heteroaryl Grignard reagent (formula IV) with an amide compound (formula V) to obtain an intermediate complex (formula VI);

Figure C20071006886600052
式IV
Figure C20071006886600053
式V
Figure C20071006886600052
Formula IV
Figure C20071006886600053
Formula V

(3)上述络合物(式VI)经过水解,再经过有机溶剂提取或蒸馏提取得到2-噻唑甲醛类化合物(式I);(3) The above complex (formula VI) is hydrolyzed, and then extracted with an organic solvent or distilled to obtain 2-thiazole formaldehyde compounds (formula I);

Figure C20071006886600054
式VI
Figure C20071006886600054
Formula VI

上述步骤中,In the above steps,

式I、式II、式IV和式VI中的R1为氢,R2为氢或乙基;R in formula I, formula II, formula IV and formula VI 1 is hydrogen, R 2 is hydrogen or ethyl;

式V和式VI中的R3和R4各自为甲基或哌嗪基;R 3 and R 4 in formula V and formula VI are each methyl or piperazinyl;

式III中的R选自C2-8烷基或C5-12杂芳基。R in formula III is selected from C2-8 alkyl or C5-12 heteroaryl.

步骤(1)格氏交换反应的反应溶剂为四氢呋喃。The reaction solvent of the step (1) Grignard exchange reaction is tetrahydrofuran.

制备中间体络合物(VI)的反应溶剂为四氢呋喃,或四氢呋喃与甲苯按体积比为1~5∶5~1之间的任意比例的混合物。The reaction solvent for preparing the intermediate complex (VI) is tetrahydrofuran, or a mixture of tetrahydrofuran and toluene in any ratio of 1-5:5-1 by volume.

步骤(3)水解络合物(式VI)所选用的水解剂为饱和氯化铵水溶液;提取用的有机溶剂为甲苯。Step (3) The selected hydrolyzing agent for hydrolyzing the complex (formula VI) is saturated ammonium chloride aqueous solution; the organic solvent used for extraction is toluene.

以上发明方案进一步叙述如下:Above invention scheme is further described as follows:

以2-溴噻唑类化合物(式II)为起始原料,通过与烷烃基或芳香烃格氏试剂(式III)发生反应,With 2-bromothiazole compound (formula II) as starting material, by reacting with alkane group or aromatic hydrocarbon Grignard reagent (formula III),

式II    RMgBr 式III Formula II RMgBr Formula III

从而得到难于直接制备的2-溴噻唑类杂芳香格氏试剂(式IV)Thereby obtain the 2-bromothiazole heteroaromatic Grignard reagent (formula IV) that is difficult to prepare directly

Figure C20071006886600061
式IV
Figure C20071006886600061
Formula IV

其中反应介质溶剂可以为醚类溶剂,也可以采用甲苯与醚类溶剂的混合溶剂,优选乙醚,四氢呋喃;烷烃基或芳香烃格氏剂(式III)优选溴乙烷,溴丙烷;其中反应温度可以为-40~80℃,优选-10~10℃。Wherein the reaction medium solvent can be ether solvent, also can adopt the mixed solvent of toluene and ether solvent, preferred ether, tetrahydrofuran; Alkane group or aromatic hydrocarbon Grignard agent (formula III) preferably bromoethane, bromopropane; Wherein reaction temperature It may be -40 to 80°C, preferably -10 to 10°C.

试验结果表明这样得到的2-溴噻唑类杂芳香格氏试剂(式IV)纯度高,反应进行速度快,反应条件也相对温和,易于制备。其中得到的2-溴噻唑类杂芳香格氏试剂(式IV)可以不做后处理,直接以其反应溶剂的溶液形式进行下步投料。The test results show that the obtained 2-bromothiazole heteroaromatic Grignard reagent (formula IV) has high purity, fast reaction speed, relatively mild reaction conditions and easy preparation. The obtained 2-bromothiazole heteroaromatic Grignard reagent (formula IV) can be fed directly in the form of a reaction solvent solution without post-treatment.

以上述方法的得到的2-溴噻唑类杂芳香格氏试剂(式IV)为原料与甲酰胺类化合物(式V)The 2-bromothiazole heteroaromatic Grignard reagent (formula IV) obtained by the above method is used as raw material and formamide compound (formula V)

Figure C20071006886600062
式V
Figure C20071006886600062
Formula V

进行反应,得到一个络合物(式VI)Carry out reaction, obtain a complex compound (formula VI)

Figure C20071006886600063
式VI
Figure C20071006886600063
Formula VI

的反应溶剂的溶液。其中反应介质溶剂可以为醚类溶剂,也可以采用甲苯与醚类溶剂的混合溶剂;单一溶剂优选乙醚,四氢呋喃;混合溶剂优选四氢呋喃和甲苯以1∶5到5∶1的比例的混合溶剂。反应原料甲酰胺类化合物(式V)优选N,N二甲基甲酰胺和N-甲酰基哌嗪。其中反应温度可以为-40~80℃,优选-10~10℃。solution of the reaction solvent. Wherein the reaction medium solvent can be an ether solvent, or a mixed solvent of toluene and an ether solvent; the preferred single solvent is ether and tetrahydrofuran; the mixed solvent is preferably a mixed solvent of tetrahydrofuran and toluene in a ratio of 1:5 to 5:1. The reaction raw material formamide compounds (formula V) are preferably N,N dimethylformamide and N-formylpiperazine. Wherein the reaction temperature may be -40-80°C, preferably -10-10°C.

这样得到的中间体络合物(式VI)的反应溶剂的溶液经过水解反应,即可得到目标产物2-噻唑甲醛类化合物(式I)。其中所选水解溶剂可以为水,有机酸或盐的水溶液,无机酸或盐的水溶液,优选水、饱和氯化铵水溶液、1~35%的盐酸、1~50%硫酸水溶液。水解温度可以为-40~80℃,优选-10~10℃。The solution of the reaction solvent of the intermediate complex compound (formula VI) obtained in this way can be hydrolyzed to obtain the target product 2-thiazole carboxaldehyde compound (formula I). Wherein the selected hydrolysis solvent can be water, organic acid or salt aqueous solution, inorganic acid or salt aqueous solution, preferably water, saturated ammonium chloride aqueous solution, 1-35% hydrochloric acid, 1-50% sulfuric acid aqueous solution. The hydrolysis temperature may be -40-80°C, preferably -10-10°C.

反应完成后,根据反应所使用介质溶剂的不同,一般可采用溶剂提取方法,得到上述2-噻唑甲醛类化合物(式I)产品,或是采取蒸馏方法得到产品。经高压液相层析(HPLC)法及气相层析法对最终产品的检测分析,结果显示,本发明上述方法所得产品中的化合物(式I)的含量均在98%以上。After the reaction is completed, according to the difference of the medium solvent used in the reaction, a solvent extraction method can generally be used to obtain the above-mentioned 2-thiazole formaldehyde compound (Formula I) product, or a distillation method can be used to obtain the product. Through the detection and analysis of the final product by high pressure liquid chromatography (HPLC) and gas chromatography, the results show that the content of the compound (Formula I) in the product obtained by the above method of the present invention is above 98%.

其中,式I、式II、式IV和式VI中的R1为氢,R2为氢或乙基;Wherein, R in formula I, formula II, formula IV and formula VI 1 is hydrogen, R 2 is hydrogen or ethyl;

式V和式VI中的R3和R4各自为甲基或哌嗪基;R 3 and R 4 in formula V and formula VI are each methyl or piperazinyl;

式III中的R选自C2-8烷基或C5-12杂芳基R in formula III is selected from C2-8 alkyl or C5-12 heteroaryl

我们以2-溴噻唑类化合物为原料,通过制备其格氏试剂,获得2-噻唑甲醛类化合物。首先,因为Mg-C键的极性比Li-C键小,因此更加稳定,所以新方法不必在超低温条件下进行。其次,对于缺电性的2-溴噻唑类化合物,直接制备其格氏试剂是很困难的事情,我们借鉴Paul Knokel等人2000年发表在J.Org.Chem上的杂环类化合物卤素-镁交换方法,首先用活泼的卤代烷烃制备其格氏试剂,然后在一定条件下将此格氏试剂与2-溴噻唑类化合物反应,成功地制得了2-溴噻唑类杂芳香格氏试剂,该方法不仅反应速度快、收率高,并且操作简单、易于工业化。We use 2-bromothiazole compounds as raw materials to obtain 2-thiazole formaldehyde compounds by preparing their Grignard reagents. First, because the Mg-C bond is less polar and therefore more stable than the Li-C bond, the new method does not have to be performed at ultra-low temperatures. Secondly, it is very difficult to directly prepare the Grignard reagents of the 2-bromothiazole compounds that are deficient in electricity. We refer to the heterocyclic compound halogen-magnesium that Paul Knokel et al. published on J.Org.Chem in 2000. The exchange method first prepares its Grignard reagent with active halogenated alkanes, and then reacts the Grignard reagent with 2-bromothiazole compounds under certain conditions to successfully prepare 2-bromothiazole heteroaromatic Grignard reagents. The method not only has fast reaction speed and high yield, but also has simple operation and easy industrialization.

综上,本发明采用先由2溴噻唑类化合物(式II)经过与廉价的脂肪烃或芳香烃格氏剂进行格氏交换反应得到2-溴噻唑类杂芳香格氏试剂(式IV),随后再使其与甲酰胺类化合物反应,经过水解从而得到目标化合物2-噻唑甲醛类化合物。与传统的2-噻唑甲醛类化合物的制备方法相比较,本发明具有如下优点:首先,反应条件温和,可以在室温、常压等温和条件下完成反应,从而大幅度地降低了对反应设备等方面的要求及费用;其次,本发明反应收率高,从而大幅度地降低了生产成本;另外,本发明可以通过简单的蒸馏方法得到高纯度产品,不必经色谱分离提纯,利于工业化操作。综上所述,本发明具有成本和技术上的优势,从而有利于使上述化合物2-噻唑甲醛类化合物(式I)实现大规模的工业化生产,具有了极大的商业应用价值。In summary, the present invention adopts 2-bromothiazole heteroaromatic Grignard reagents (formula IV) by first carrying out Grignard exchange reaction with cheap aliphatic or aromatic hydrocarbon Grignard agents from 2-bromothiazole compounds (formula II), Then make it react with formamide compounds, and undergo hydrolysis to obtain the target compound 2-thiazole carboxaldehyde compounds. Compared with the traditional preparation method of 2-thiazole formaldehyde compounds, the present invention has the following advantages: first, the reaction conditions are mild, and the reaction can be completed at room temperature, normal pressure and other mild conditions, thereby greatly reducing the need for reaction equipment, etc. Second, the present invention has a high reaction yield, thereby greatly reducing production costs; in addition, the present invention can obtain high-purity products through simple distillation methods without chromatographic separation and purification, which is beneficial to industrial operations. To sum up, the present invention has cost and technical advantages, which is conducive to the large-scale industrial production of the above-mentioned compound 2-thiazole carboxaldehyde (Formula I), and has great commercial application value.

具体实施方式 Detailed ways

本发明的方法可设计成用于实验室和工业规模,以下将参考实施例来描述本发明。The method of the present invention can be designed for laboratory and industrial scale, and the present invention will be described below with reference to examples.

实施例1Example 1

2-溴噻唑格氏试剂的制备Preparation of 2-bromothiazolyl Grignard reagent

在-500ml四口瓶中投入浓度为2mol/L的溴乙烷格氏试剂/四氢呋喃溶液200ml(0.40mol),搅拌,冰水浴冷却至0~5℃,缓慢滴加入2-溴噻唑59g(0.36mol),约0.5小时滴毕,继续于0℃反应2小时。TLC检测,原料2-溴噻唑反应完全。取反应液0.5ml置于试管中,加入乙酸乙酯和0.1N稀盐酸各2ml,震荡,分层,取有机层作GC分析,原料2-溴噻唑含量小于1%。200ml (0.40mol) of bromoethane Grignard reagent/tetrahydrofuran solution with a concentration of 2mol/L was put into a -500ml four-necked flask, stirred, cooled in an ice-water bath to 0-5°C, and 59g (0.36 mol), after about 0.5 hours, the reaction was continued at 0°C for 2 hours. As detected by TLC, the raw material 2-bromothiazole was completely reacted. Take 0.5ml of the reaction solution and place it in a test tube, add 2ml each of ethyl acetate and 0.1N dilute hydrochloric acid, shake, separate layers, take the organic layer for GC analysis, the content of the raw material 2-bromothiazole is less than 1%.

实施例2Example 2

2-噻唑甲醛的制备Preparation of 2-thiazolecarbaldehyde

(1)在一1000ml四口瓶中,投入甲苯200mL,N,N二甲基甲酰胺73g(1.0mol),搅拌,水浴冷却至5~10℃,将上述实例1中所得2-溴噻唑格氏试剂溶液,缓慢加入,毕,于10℃搅拌反应12小时左右。在另一1000ml四口瓶中,得投入2N盐酸200ml,水浴控温15℃左右,将上述反应液缓慢加入其中,搅拌0.5小时,静置分层,水层继续用200ml甲苯提取两次;合并有机层,用100ml水洗涤,无水MgSO4干燥0.5小时,过滤,母液于70℃减压浓缩至干,(1) In a 1000ml four-necked flask, put 200mL of toluene, 73g (1.0mol) of N,N dimethylformamide, stir, and cool in a water bath to 5-10°C. Stirring reagent solution, slowly added, after completion, stirred and reacted at 10°C for about 12 hours. In another 1000ml four-necked bottle, put 200ml of 2N hydrochloric acid into it, and control the temperature in a water bath at about 15°C. Slowly add the above reaction solution into it, stir for 0.5 hours, let it stand for stratification, and continue to extract the water layer twice with 200ml of toluene; combine The organic layer was washed with 100ml of water, dried over anhydrous MgSO for 0.5 hours, filtered, and the mother liquor was concentrated to dryness at 70°C under reduced pressure,

获淡红色液体40.5g,经GC分析,2-噻唑甲醛的含量为86%,粗品收率99%。40.5 g of a light red liquid was obtained. According to GC analysis, the content of 2-thiazole formaldehyde was 86%, and the crude product yield was 99%.

(2)取上述所得2-噻唑甲醛粗品40.0g真空蒸馏,真空度2Hgmm,收集41℃馏分,得微黄色液体28.2g,收率70.5%。沸点154℃,GC检测2-溴噻唑含量98.8%。(2) Take 40.0 g of the above obtained 2-thiazole formaldehyde crude product and vacuum distill it at a vacuum degree of 2 Hgmm, collect fractions at 41° C. to obtain 28.2 g of a yellowish liquid with a yield of 70.5%. The boiling point is 154°C, and the content of 2-bromothiazole detected by GC is 98.8%.

1HNMR(CDCl3):δ(ppm)=7.82(d,3Hz,1H),8.16(d,3Hz,1H),10.04(s,1H). 1 HNMR(CDCl 3 ): δ(ppm)=7.82(d, 3Hz, 1H), 8.16(d, 3Hz, 1H), 10.04(s, 1H).

13CNMR(CDCl3):δ(ppm)=126.4,149.6,165.9,184.9. 13 CNMR (CDCl 3 ): δ (ppm) = 126.4, 149.6, 165.9, 184.9.

实施例3Example 3

4-乙基-2-溴噻唑格氏试剂的制备Preparation of 4-ethyl-2-bromothiazole Grignard reagent

在反应瓶A中,投入4-乙基-2-溴噻唑38.4g(0.20mol),乙醚100ml,搅拌,冷却至-5~0℃,缓慢加入浓度为2mol/L的溴丙烷格氏剂/乙醚的溶液120ml(0.24mol),15分钟加毕。于0℃左右,继续搅拌反应3小时,TLC检测原料4-乙基-2-溴噻唑基本反应完全。取反应液0.5ml置于试管中,加入乙酸乙酯和0.1N稀盐酸各2ml,震荡,分层,取有机层作GC分析,原料4-乙基-2-溴噻唑少于2%。In reaction flask A, put 38.4g (0.20mol) of 4-ethyl-2-bromothiazole and 100ml of diethyl ether, stir, cool to -5~0°C, slowly add bromopropane Grignard agent with a concentration of 2mol/L/ 120ml (0.24mol) of ether solution was added in 15 minutes. At about 0°C, the stirring reaction was continued for 3 hours, and the reaction of the raw material 4-ethyl-2-bromothiazole was basically complete as detected by TLC. Take 0.5ml of the reaction solution and put it in a test tube, add 2ml each of ethyl acetate and 0.1N dilute hydrochloric acid, shake, separate layers, take the organic layer for GC analysis, the raw material 4-ethyl-2-bromothiazole is less than 2%.

实施例4Example 4

4-乙基-2-甲酰噻唑的制备Preparation of 4-ethyl-2-formylthiazole

(1)由实施例3所得,反应瓶A内的反应液升温至10~15℃,缓慢滴加入N-甲酰基哌嗪56.5g(0.50mol),控制温度不超过20℃,约1小时滴毕。于15℃左右,继续反应8小时。中止反应。在另一反应瓶B中,投入2N盐酸200ml,乙酸乙酯200ml,水浴控温15℃左右,将上述反应液缓慢加入其中,搅拌0.5小时,静置分层,水层继续用150ml乙酸乙酯提取两次;合并有机层,用100ml水洗涤,无水MgSO4干燥0.5小时,过滤,母液减压浓缩至干,得棕色液体27.2g,GC分析,4-乙基-2-噻唑甲醛的含量为82%,粗收率96.5%。(1) As obtained in Example 3, the temperature of the reaction liquid in the reaction bottle A was raised to 10-15°C, and 56.5 g (0.50 mol) of N-formylpiperazine was slowly added dropwise, and the temperature was controlled not to exceed 20°C for about 1 hour. complete. At about 15°C, the reaction was continued for 8 hours. Abort the reaction. In another reaction bottle B, put 200ml of 2N hydrochloric acid, 200ml of ethyl acetate, and control the temperature in a water bath at about 15°C. Slowly add the above reaction solution into it, stir for 0.5 hours, let stand to separate layers, and continue to wash the water layer with 150ml of ethyl acetate. Extract twice; Merge organic layer, wash with 100ml water, anhydrous MgSO Dry 0.5 hour, filter, mother liquor is concentrated to dryness under reduced pressure, obtain brown liquid 27.2g, GC analysis, the content of 4-ethyl-2-thiazole formaldehyde is 82%, crude yield 96.5%.

(2)取上述所得4-乙基-2-甲酰噻唑粗品27.0g真空蒸馏,真空度2mmHg,收集47℃馏分,得黄色液体19.8g,收率73.3%。沸点154℃,GC检测4-乙基-2-甲酰噻唑含量98.6%。1HNMR(CDCl3):(2) 27.0 g of the crude 4-ethyl-2-formylthiazole obtained above was vacuum distilled at a vacuum degree of 2 mmHg, and fractions at 47° C. were collected to obtain 19.8 g of a yellow liquid with a yield of 73.3%. The boiling point is 154°C, and the content of 4-ethyl-2-formylthiazole detected by GC is 98.6%. 1 HNMR (CDCl 3 ):

δ(ppm)=1.24(t,7Hz,3H),2.59(q,5Hz,2H),7.41(s,1H),9.61(s,1H).δ(ppm)=1.24(t, 7Hz, 3H), 2.59(q, 5Hz, 2H), 7.41(s, 1H), 9.61(s, 1H).

13CNMR(CDCl3):δ(ppm)=14.3,25.9,114.9,153,153,190.0 13 CNMR (CDCl 3 ): δ (ppm) = 14.3, 25.9, 114.9, 153, 153, 190.0

上述具体实例所代表的实施方式是对本发明内容的详细说明,但不应该将此理解为本发明上述主体的范围仅限于以上的具体实施方式。凡基于本发明内容所实现的技术均属于本发明的范围。The implementations represented by the above specific examples are detailed descriptions of the content of the present invention, but it should not be understood that the scope of the above-mentioned subject of the present invention is limited to the above specific implementations. All technologies implemented based on the content of the present invention belong to the scope of the present invention.

Claims (5)

1.制备2-噻唑甲醛类化合物(式I)的方法,其特征在于下述步骤:1. the method for preparing 2-thiazole formaldehyde compound (formula I), is characterized in that following steps:
Figure C2007100688660002C1
Figure C2007100688660002C1
(1)用2-溴噻唑官能团衍生物(式II)与卤代烃格氏试剂RMgBr(式III)进行格氏交换反应,得到杂芳基格氏试剂(式IV);(1) Carry out Grignard exchange reaction with 2-bromothiazole functional group derivative (formula II) and halogenated hydrocarbon Grignard reagent RMgBr (formula III) to obtain heteroaryl Grignard reagent (formula IV);
Figure C2007100688660002C2
RMgBr式III
Figure C2007100688660002C2
RMgBr III
(2)将杂芳基格氏试剂(式IV)与酰胺类化合物(式V)反应,得到中间体络合物(式VI);(2) reacting a heteroaryl Grignard reagent (formula IV) with an amide compound (formula V) to obtain an intermediate complex (formula VI);
Figure C2007100688660002C3
Figure C2007100688660002C3
(3)上述络合物(式VI)经过水解,再经过有机溶剂提取或蒸馏提取得到2-噻唑甲醛类化合物(式I);(3) The above complex (formula VI) is hydrolyzed, and then extracted with an organic solvent or distilled to obtain 2-thiazole formaldehyde compounds (formula I);
Figure C2007100688660002C4
Figure C2007100688660002C4
上述步骤中,In the above steps, 式I、式II、式IV和式VI中的R1为氢,R2为氢或乙基;R in formula I, formula II, formula IV and formula VI 1 is hydrogen, R 2 is hydrogen or ethyl; 式V和式VI中的R3和R4都为甲基;R 3 and R 4 in formula V and formula VI are methyl; 式III中的R选自C2-8烷基或C5-12杂芳基。R in formula III is selected from C2-8 alkyl or C5-12 heteroaryl.
2.根据权利要求1制备2-噻唑甲醛类化合物(式I)的方法,其特征在于:步骤(1)格氏交换反应的反应溶剂为四氢呋喃。2. according to the method for preparing 2-thiazole formaldehyde compound (formula I) according to claim 1, it is characterized in that: the reaction solvent of step (1) Grignard exchange reaction is tetrahydrofuran. 3.根据权利要求1制备2-噻唑甲醛类化合物(式I)的方法,其特征在于:制备中间体络合物(VI)的反应溶剂为四氢呋喃,或四氢呋喃与甲苯按体积比为1~5∶5~1之间的任意比例的混合物。3. according to the method for preparing 2-thiazole formaldehyde compound (formula I) according to claim 1, it is characterized in that: the reaction solvent of preparation intermediate complex compound (VI) is tetrahydrofuran, or tetrahydrofuran and toluene are 1~5 by volume : A mixture of any ratio between 5 and 1. 4.根据权利要求1制备2-噻唑甲醛类化合物(式I)的方法,其特征在于:步骤(3)水解络合物(式VI)所选用的水解剂为饱和氯化铵水溶液。4. The method for preparing 2-thiazole formaldehyde compound (formula I) according to claim 1, characterized in that: the hydrolyzing agent selected for step (3) hydrolysis complex (formula VI) is a saturated aqueous ammonium chloride solution. 5.根据权利要求1制备2-噻唑甲醛类化合物(式I)的方法,其特征在于:步骤(3)提取用的有机溶剂为甲苯。5. according to the method for preparing 2-thiazole formaldehyde compounds (formula I) according to claim 1, it is characterized in that: the organic solvent that step (3) extracts is toluene.
CNB2007100688666A 2007-05-17 2007-05-17 The preparation method of 2-thiazole carboxaldehyde compounds Expired - Fee Related CN100548995C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2007100688666A CN100548995C (en) 2007-05-17 2007-05-17 The preparation method of 2-thiazole carboxaldehyde compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2007100688666A CN100548995C (en) 2007-05-17 2007-05-17 The preparation method of 2-thiazole carboxaldehyde compounds

Publications (2)

Publication Number Publication Date
CN101050204A CN101050204A (en) 2007-10-10
CN100548995C true CN100548995C (en) 2009-10-14

Family

ID=38781828

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2007100688666A Expired - Fee Related CN100548995C (en) 2007-05-17 2007-05-17 The preparation method of 2-thiazole carboxaldehyde compounds

Country Status (1)

Country Link
CN (1) CN100548995C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116425697A (en) * 2023-01-31 2023-07-14 滕州市悟通香料有限责任公司 A kind of method of synthesizing 2-acetylthiazole

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Selective metallation of thiophene and thiazole ringswithmagnesium amide base. Manabu Shilai, et al.J. Chem. Soc., Perkin Trans. 1. 2001 *
Synthesis and Configurational Assignment of the AminoAlcohol in the Eastern Fragment of the GE2270 Antibiotics byRegio- and Stereoselective Addition of 2-Metalated4-Bromothiazoles to α-Chiral Electrophiles. Oscar Delgado, et al.J. Org. Chem.,Vol.71 No.12. 2006 *

Also Published As

Publication number Publication date
CN101050204A (en) 2007-10-10

Similar Documents

Publication Publication Date Title
CN103524440B (en) The preparation method of gout therapertics Lesinurad and Lesinurad intermediate
CN110183378A (en) A kind of derivative and its process for catalytic synthesis of niacinamide
CN105330634A (en) One-pot method for preparing 3-hydroxyphtalic anhydride
CN100548995C (en) The preparation method of 2-thiazole carboxaldehyde compounds
CN106986886B (en) A kind of preparation method of the fluoro- 3- Trifluoromethoxyphen-l pinacol borate of 4-
CN110903238B (en) Preparation method of kovar stat
CN103772189B (en) Synthesis method of diethylstilbestrol compound methyl pigeon pea ketonic acid A
CN115304542B (en) A kind of synthesis technology of 3-hydroxypyridine
CN101121692A (en) Synthetic method of α-carbonyl amides
CN110003101B (en) Apatinib intermediate and preparation method thereof
CN106336378B (en) Preparation method of quinoline-2-formic ether series
CN108033990A (en) The preparation method of Dexamethasone Intermediate
CN113024411B (en) Preparation method of tralkoxydim
CN114702425A (en) Preparation method of (S) -2-amino- (S) -3- [ pyrrolidone-2' ] alanine derivative and intermediate
CN101486694B (en) The preparation method of 2,5-dimethylfuran-3,4-diethyl carboxylate
CN114790133A (en) Method for synthesizing 2-chloro-4-fluorobenzoic acid by taking 2-chloro-4-aminobenzonitrile as raw material
CN106748797A (en) A kind of preparation method of the naphthol derivative of 2 nitro 1
CN106380469A (en) Synthesis method of 1-aromatic carbonyl-2-aryl-3-ester imidazolone compounds
CN101787035A (en) Preparation method of 7-aminocephalo-5-mercapto-1-methyltetrazole
CN105330525A (en) Preparation method of 7-hydroxy-1-indanone
CN101747343B (en) A kind of preparation method of sulbactam pivoxil
CN105732547A (en) Preparation method of dehydrated andrographolide diacid half ester basic salt
CN112479908B (en) A preparation method of salbutamol sulfate impurity D
CN102558089B (en) Method for preparation and purification of 2-(4-methyl-1-piperazinyl)-4- thiazolinone
CN110016030B (en) Preparation method of 5-fluoro-1H-pyrrole- [2,3-b ] pyridine-4-formaldehyde

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: Zhejiang Zhongbei Chemical Co.,Ltd.

Assignor: ZHEJIANG JIUZHOU PHARMACEUTICAL Co.,Ltd.

Contract record no.: 2010330001901

Denomination of invention: Method for preparing compound of thiazole formaldehyde class

Granted publication date: 20091014

License type: Exclusive License

Open date: 20071010

Record date: 20100920

PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Preparation of 2-thiazole formaldehyde compounds

Effective date of registration: 20210727

Granted publication date: 20091014

Pledgee: Agricultural Bank of China Limited by Share Ltd. Taizhou Jiaojiang branch

Pledgor: Zhejiang Jiuzhou Pharmaceutical Co.,Ltd.

Registration number: Y2021330000998

PE01 Entry into force of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20211216

Granted publication date: 20091014

Pledgee: Agricultural Bank of China Limited by Share Ltd. Taizhou Jiaojiang branch

Pledgor: ZHEJIANG JIUZHOU PHARMACEUTICAL Co.,Ltd.

Registration number: Y2021330000998

PC01 Cancellation of the registration of the contract for pledge of patent right
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091014